Cardiac safety concerns for ondansetron, an antiemetic commonly used for nausea linked to cancer treatment and following anaesthesia

Author： Doggrell Sheila A  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.12, Iss.3, 2013-05, pp. : 421-431

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiac safety concerns for domperidone, an antiemetic and prokinetic, and galactogogue medicine

By Doggrell Sheila A   Hancox Jules C  

Expert Opinion on Drug Safety, Vol. 13, Iss. 1, 2014-01 ,pp. : 131-138

Informa Healthcare

Access to resources Recommend Favorite

The cardiac safety of trastuzumab in the treatment of breast cancer

By Chien A Jo   Rugo Hope S  

Expert Opinion on Drug Safety, Vol. 9, Iss. 2, 2010-03 ,pp. : 335-346

Informa Healthcare

Access to resources Recommend Favorite

Prevention of Postoperative Nausea and Vomiting after Thyroidectomy: Combined Antiemetic Treatment with Dexamethasone and Ginger versus Dexamethasone Alone

By Tavlan Aybars   Tuncer Sema   Erol Atilla   Reisli Ruhiye   Aysolmaz Gökhan   Otelcioglu Seref  

Clinical Drug Investigation, Vol. 26, Iss. 4, 2006-01 ,pp. : 209-214

Adis International

Access to resources Recommend Favorite

Ondansetron: A Review of its Use as an Antiemetic in Children

By Culy C.R.   Bhana N.   Plosker G.L.  

Pediatric Drugs, Vol. 3, Iss. 6, 2001-01 ,pp. : 441-479

Adis International

Access to resources Recommend Favorite

Glivec EU-SPC updated following safety concerns

By  

Reactions Weekly, Vol. 1, Iss. 1135, 2007-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite